Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
BBX | hg38_v1_chr3_+_107524357_107524376 | 0.11 | 5.5e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_+_154563003 Show fit | 5.60 |
ENST00000302068.9
ENST00000509493.1 |
fibrinogen beta chain |
|
chr7_-_16881967 Show fit | 3.47 |
ENST00000402239.7
ENST00000310398.7 ENST00000414935.1 |
anterior gradient 3, protein disulphide isomerase family member |
|
chr16_+_56638659 Show fit | 3.18 |
ENST00000290705.12
|
metallothionein 1A |
|
chr11_+_60699605 Show fit | 3.18 |
ENST00000300226.7
|
membrane spanning 4-domains A8 |
|
chr2_-_215393126 Show fit | 2.53 |
ENST00000456923.5
|
fibronectin 1 |
|
chr9_-_92404559 Show fit | 2.49 |
ENST00000262551.8
ENST00000375561.10 |
osteoglycin |
|
chr7_-_16833411 Show fit | 2.41 |
ENST00000412973.1
|
anterior gradient 2, protein disulphide isomerase family member |
|
chr11_+_60699669 Show fit | 2.27 |
ENST00000529752.5
|
membrane spanning 4-domains A8 |
|
chr3_-_58666765 Show fit | 2.27 |
ENST00000358781.7
|
FAM3 metabolism regulating signaling molecule D |
|
chr2_+_102311546 Show fit | 2.20 |
ENST00000233954.6
ENST00000447231.5 |
interleukin 1 receptor like 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 7.1 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.4 | 5.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 4.6 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.5 | 3.8 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.8 | 3.2 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
0.1 | 3.2 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.2 | 3.1 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.9 | 2.6 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
0.8 | 2.5 | GO:1904235 | regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
0.5 | 2.4 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 8.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 6.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 5.2 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 5.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.5 | 3.2 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.3 | 2.6 | GO:0044305 | calyx of Held(GO:0044305) |
0.0 | 2.4 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 1.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 1.6 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 1.6 | GO:0031526 | brush border membrane(GO:0031526) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 8.1 | GO:0051087 | chaperone binding(GO:0051087) |
0.2 | 6.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 5.8 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 4.1 | GO:0008083 | growth factor activity(GO:0008083) |
1.3 | 3.8 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.8 | 3.2 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.1 | 3.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 2.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.5 | 2.1 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.0 | 1.9 | GO:0005518 | collagen binding(GO:0005518) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 8.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 6.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 1.6 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 1.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 5.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 4.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 3.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 2.5 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 2.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 2.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 1.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 1.1 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |